Recruiting Chronic Urticaria Studies in Birmingham
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating ...
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines
This is a Phase 3, parallel group, placebo-controlled, double-blind, confirmatory study in patients with CINDU, with an optional Open-label Extension (OLE). The purpose of the core period (52 weeks o...
Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)
This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe chronic spontaneous urticaria (CSU)....
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
This is a 2-part, proof-of-concept study to be conducted globally, designed to evaluate the safety, tolerability, clinical activity, pharmacokinetics, and pharmacodynamics of BLU-808, a wild type KIT ...
Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)
This trial will be performed as a three-part dose escalating clinical trial where Parts 1 is open label and Parts 2 and 3 are randomized, double-blinded, and placebo-controlled. The trial is intended...
About Chronic Urticaria Clinical Trials in Birmingham
Chronic urticaria involves recurring episodes of itchy, red welts (hives) lasting more than six weeks. Chronic spontaneous urticaria (CSU) occurs without an identifiable trigger. Treatment includes antihistamines and biologics like omalizumab.
There are currently 5 chronic urticaria clinical trials recruiting participants in Birmingham, . These studies are seeking a combined 1,608 participants. Research is being sponsored by Celldex Therapeutics, Novartis Pharmaceuticals, Evommune, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Chronic Urticaria Clinical Trials in Birmingham — FAQ
Are there chronic urticaria clinical trials in Birmingham?
Yes, there are 5 chronic urticaria clinical trials currently recruiting in Birmingham, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Birmingham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.
Are clinical trials in Birmingham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.
What chronic urticaria treatments are being tested?
The 5 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for chronic urticaria.
Data updated March 2, 2026 from ClinicalTrials.gov